Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, on Oral Hypoglycemic Treatment”

53 trials

Showing 20 of 53 results

Not applicableStudy completedNCT00563004
What this trial is testing

The Effect of DBcare, a Food Supplement on Diabetes Control

Who this might be right for
Diabetes Mellitus, Non-insulin DependantDiabetes Mellitus Type 2Diabetes Mellitus, on Oral Hypoglycemic Treatment+1 more
Meir Medical Center 35
Not applicableStudy completedNCT00687284
What this trial is testing

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,188
Large-scale testing (Phase 3)Study completedNCT03798080
What this trial is testing

Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 426
Post-approval studies (Phase 4)Study completedNCT00807092
What this trial is testing

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 145
Testing effectiveness (Phase 2)Study completedNCT00382239
What this trial is testing

Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 153
Large-scale testing (Phase 3)Study completedNCT00673231
What this trial is testing

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,240
Not applicableStudy completedNCT00865397
What this trial is testing

Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,032
Post-approval studies (Phase 4)Study completedNCT01698931
What this trial is testing

Efficacy of Repaglinide in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9
Large-scale testing (Phase 3)Study completedNCT00653341
What this trial is testing

Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 764
Not applicableStudy completedNCT00740519
What this trial is testing

Observational Study on Safety of Self-titration of Once Daily Levemir®

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 882
Post-approval studies (Phase 4)Study completedNCT00941369
What this trial is testing

Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 345
Large-scale testing (Phase 3)Study completedNCT02268214
What this trial is testing

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 833
Post-approval studies (Phase 4)Study completedNCT00405418
What this trial is testing

Lantus Versus Levemir Treat-To-Target

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 973
Large-scale testing (Phase 3)Study completedNCT01798706
What this trial is testing

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes
Sanofi 350
Post-approval studies (Phase 4)Study completedNCT02954692
What this trial is testing

Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 112
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Not applicableStudy completedNCT00700960
What this trial is testing

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,745
Not applicableStudy completedNCT01859598
What this trial is testing

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Who this might be right for
Diabetes
The George Institute for Global Health, China 19,894
Large-scale testing (Phase 3)Ended earlyNCT03434119
What this trial is testing

Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 241
Large-scale testing (Phase 3)Study completedNCT01697592
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 585
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation